Past Speakers & Companies

Key Scientists & Experts

Melanie Ott, MD, PhD

Director, Gladstone Institute of Virology

David Sinclair

Co-Director, Glenn Center for Aging Research, Professor at Harvard Medical School

Eric Verdin, MD

President and CEO, Buck Institute for Research on Aging

George Church PhD

Founding Core Faculty & Lead, Wyss Institute at Harvard University

Mary Lou Jepsen, PhD

CEO and Founder, OpenWater

Shinya Yamanaka, MD, PhD

Nobel Prize laureate & L.K. Whittier Foundation Investigator in Stem Cell Biology, Gladstone Institutes

Jennifer Garrison, PhD

Co-Founder & Director, Global Consortium for Reproductive Longevity & Equality

Sandra Kaufmann, MD

Author and Creator of the Kaufmann Protocol

Timothy Nelson, MD, PhD

Founder & CEO, Heartworks

Alessandra Zonari, PhD

Co-Founder and Chief Scientific Officer, OneSkin

Robin Mansukhani

CEO and Co-Founder, Deciduous Therapeutics

Kyle Zagrodsky

Founder & CEO, OsteoStrong Franchising

Joshua Ofman, MD, MSHS

President and Chief Medical Officer

Daniel Kraft, MD

Founder & Chair, Exponential Medicine

Josh Clemente

Founder, Levels

Jon Carder

Co-Founder & CEO, Vessel Health

Dr. Trevor Martin

Co Founder, Mammoth Biosciences

Kristen Fortney, PhD

Co Founder and CEO, BioAge

Naveen Jain

Author, Moonshots: Creating a World of Abundance

Morgan Levine, PhD

Founding Principal Investigator, Altos Labs

Daniel Oliver

Co Founder and CEO, Rejuvenate Bio

Dean Ornish, MD

Founder and President, Preventive Medicine Research Institute

Priya Abani

CEO, President, and Board Member, AliveCor

James Min, MD

Founder and CEO, Cleerly

Katerina Akassoglou, PhD

Professor of Neurology, UC San Francisco (UCSF)

Yadong Huang, MD, PhD

Scientific Co-Founder, GABAeron

James Nestor

Science Journalist and Author, Breath

Tara Tracy, PhD

Assistant Professor, Buck Institute for Research on Aging

Seth Shipman, PHD

Assistant Professor, Gladstone Institutes at UCSF

George Shapiro, MD

Chief Medical Innovation Officer, Fountain Life

Matt Walker, PhD

Professor, UC Berkeley

Bjoern Woltermann

Founder & CEO, Katalyst

Denitsa Milanova, PhD

Fellow & PI, Marble Therapeutics

Sandeep Akkaraju

CEO & President, Exo Imaging

Greg Bailey, MD

CEO, Juvenescence

Hector L. LopezMD, CSCS, FAAPMR

Chief Research and Innovation Advisor, LIFEFORCE

Carolina Reis

CEO, OneSkin

Leor Weinberger, PhD

Co-Founder, VxBiosciences

John Jaquish, PhD

Inventor, OsteoStrong Devices

Kenneth R. Brown, DDS

Co-Founder & CEO, Feno

David Furman, PhD

Associate Professor, Buck Institute for Research on Aging

Isha Jain, PhD

Assistant Professor, Gladstone Institutes and UCSF

Kyle Zagrodzky

Founder & CEO, OsteoStrong Franchising

Deepak Srivastava, MD

President, Gladstone Institutes

David Fagjenbaum, MD

Physician-Scientist, University of Pennsylvania

Brianna Stubbs, PhD

Lead Translational Scientist, Buck Institute for Research on Aging

Noah Davidsohn, PhD

CSO, Co-Founder, Rejuvenate Bio

Kent Wakeford

Co Founder, Chief Operating Officer, Colossal

Alex Aravanis MD PhD

Chief Technology Officer, Illumina

Remy Gross III

Vice President, Business Development and Technology Advancement, Buck Institute for Research on Aging

Longevity & Biotech Topics

Delve into the next decade of longevity and biotechnology innovations across:

Regenerative Medicine
Cancer Detection, Prevention & Therapies
Sirtuin Activators
Gene Therapy & CRISPR
Brain Health & Neurodegenerative Diseases
Tissue & Organ Engineering
Brain-Immune-Gut Axis
Senolytic Medicines
Increasing Vitality

A 5-day Longevity Deep-Dive with Peter Diamandis, MD

The 2023 Platinum Longevity Trip is a luxury 5-day deep dive into the future of your health, spanning key therapies, research, and novel breakthroughs that will define the next decade of longevity: regenerative medicine and stem cell therapies, advancements in brain health and prevention of neurodegenerative diseases, CRISPR and gene therapies, senolytic medicines, advanced diagnostics, and others.

The trip offers first-hand exposure to the pioneering founders, scientists, startups, public biotech companies and treatments in longevity and vitality. Gain an exclusive view of what is coming our way this next decade in personalized, preventive medicine, and rejuvenation treatments.

Untitled-2

High-Level details

What's Included

  • 5-star accommodation
  • Private charter service & all internal transit
  • Haute cuisine menus
  • Wellness treatments
  • Advanced diagnostics

Cost

Individual Rate: $70,000

Couple's Rate: $65,000 / person

Day 1-3: Boston
Boston
Trip 1: Aug 16-18
Trip 2: Sep 27-29
Day 4: Verijet Private Flight to New York
Mask Group 39
Trip 1: Aug 19
Trip 2: Sep 30
Day 4-5: New York
New York
Trip 1: Aug 19-20
Trip 2: Sep 30-Oct 1
REGISTER NOW

Personalized for 40 extraordinary people

 

Limited to an exclusive group of serious players (C-suite executives, investors, industry leaders) worldwide, Abundance Platinum is about fostering lifelong friendships.

Our group will additionally be joined by resident longevity experts that will accompany and advise members throughout the trip.

Through a personalization process, Peter and his team work to determine what therapies, health concerns (involving family medical history), investment interests, and conditions are most important to you. The experience is then curated through our various symposiums, featured treatments, and hosted experts to emphasize your most pressing interests.

Trip overview by topic

Day 0

Itinerary

  • Arrive in San Francisco
  • Check in: St. Regis San Francisco

Day 1

Topics

  • Gene Therapy
  • Young Blood & GDF11
  • Brain-Immune-Gut Axis
  • CRISPR & Genetic Engineering

Day 2

Topics

  • Tissue Engineering
  • Sensors & Wearables
  • COVID-19 & Future of Pandemics
  • Regenerative Medicine
  • Brain Health

Day 3

Topics

  • Neurodegenerative Diseases
  • Cardiovascular Health
  • Oncology & Cancer Therapies
  • NAD+ / Sirtuins Diagnostics Biofabrication

Day 4

Itinerary

  • Flight to San Diego
  • Check in: Park Hyatt Aviara

Topics

  • Biological Mechanics of Aging
  • Cellular Therapies

Day 5

Topics

  • Stem Cells
  • Drug Discovery: Age-Related Diseases
  • Organ Procurement
  • The Future of Aging
  • Closing Reception

Message from Peter H. Diamandis, MD

My mission is to transform your mindset around longevity. To give you overwhelming evidence of the massive medical advancements that are already beginning to extend the human healthspan.

Now more than ever, during a period of exponential medicine, you don’t have to accept the cards you’re dealt. Technologies like genome sequencing, RNA transcriptomics, Wnt pathway modifiers, vaccines, CRISPR, liquid biopsies, CAR-T cells, Gene Therapy, exosomes, and stem cells are just a few of the technologies under development. My goal through these 5 days is to fundamentally reframe your concept of aging as a disease -- a disease that many are beginning to believe can be slowed, stopped and perhaps even reversed.

Join me on the journey of a lifetime, get a behind-the-scenes look at the decade ahead in longevity-extending technologies, and begin adding healthy decades onto your life.

About Peter

Fortune Magazine named Diamandis as one of the World’s 50 Greatest Leaders. He is the Founder & Executive Chairman of the XPRIZE Foundation and Executive Founder of Singularity University and has co-Founded 20 companies including Celularity, Human Longevity Inc., and BOLD Capital Partners. Diamandis is the NY Times Bestselling author of Abundance and BOLD. He earned degrees in Molecular Genetics and Aerospace Engineering from MIT, and an MD from Harvard Medical School.